The fusion peptide (FP) of HIV-1 envelope glycoprotein (Env) is essential for mediating viral entry. Detection of broadly neutralizing antibodies (bnAbs) that interact with the FP has revealed it as a site of vulnerability. We delineate X-ray and cryo-electron microscopy (cryo-EM) structures of bnAb ACS202, from an HIV-infected elite neutralizer, with an FP and with a soluble Env trimer (AMC011 SOSIP.v4.2) derived from the same patient. We show that ACS202 CDRH3 forms a ''b strand'' interaction with the exposed hydrophobic FP and recognizes a continuous region of gp120, including a conserved N-linked glycan at N88. A cryo-EM structure of another previously identified bnAb VRC34.01 with AMC011 SOSIP.v4.2 shows that it also penetrates through glycans to target the FP. We further demonstrate that the FP can twist and present different conformations for recognition by bnAbs, which enables approach to Env from diverse angles. The variable recognition of FP by bnAbs thus provides insights for vaccine design.
In Brief
The HIV-1 Env fusion peptide (FP) is a site of vulnerability targeted by the immune system. Yuan et al. show that broadly neutralizing antibody ACS202 penetrates the Env glycan shield to target the FP. The diverse approach angles to the FP by different neutralizing antibodies provide insights for vaccine design.
INTRODUCTION
The elicitation of potent broadly neutralizing antibodies (bnAbs) by vaccination is thought to be critical for protecting against HIV-1 infection. The only target for bnAbs on HIV-1 is the trimeric envelope glycoprotein (Env) spike. Numerous bnAbs to HIV-1 have been discovered, especially in the last 10 years, and have revealed an unexpectedly large number of sites of vulnerability (Chuang et al., 2019; McCoy, 2018; Sok and Burton, 2018) , including the CD4-binding site, V1/V2 apex, N332/V3 base supersite, membrane-proximal external region (MPER), and, more recently, the gp120-gp41 interface.
The bnAbs targeting the gp120-gp41 interface include 8ANC195 (Scharf et al., 2014; Scheid et al., 2011) , 35O22 (Huang et al., 2014) , PGT151 Falkowska et al., 2014) , VRC34.01 , and CAP248-2B (Wibmer et al., 2017) . Most of these bnAbs are trimer specific and gp120-gp41 cleavage dependent. The HIV-1 Env glycoprotein is assembled as a trimer of heterodimers, with three gp120 membrane-distal subunits and three gp41 membrane-proximal and transmembrane subunits. Upon endoproteolytic cleavage of the gp160 precursor, the N-terminal region (fusion peptide, FP) of gp41 (Blumenthal et al., 2012) is liberated. The FP is hydrophobic ( Figure S1A ), largely disordered (Guttman et al., 2014; Kumar et al., 2019) , generally but not completely conserved in sequence (Figures S1B-S1D) , and essential for virus entry because of its critical involvement in membrane fusion (Blumenthal et al., 2012) . Extrapolation from how the FP is oriented in the pre-fusion state of the influenza hemagglutinin (HA) glycoprotein (Wilson et al., 1981 ) generated the hypothesis that the HIV-1 Env FP would likely be inaccessible in the gp120-gp41 interface, as a device to prevent non-specific hydrophobic interactions or premature fusion. However, bnAbs PGT151 and VRC34.01 were found to interact with the FP, as well as other components including complex glycans nearby in the gp120-gp41 interface (Lee et al., 2016) .
The ACS202 bnAb was isolated from an HIV-1-infected individual, AMC011, who was categorized as an ''elite neutralizer'' (van den Kerkhof et al., 2014; van Gils et al., 2016) . AMC011 sera showed early broad HIV-1 neutralizing activity; ACS202 bnAb was isolated later in infection, exhibited 45% breadth on a panel of 87 viruses, and was shown to target the FP and N88 (van den Kerkhof et al., 2014; van Gils et al., 2016) . Here, we define how bnAb ACS202 recognizes Env by determining its X-ray structure in complex with the FP and its cryo-electron microscopy (cryo-EM) structure in complex with a SOSIP.v4.2 Env trimer that was derived from the same elite neutralizer AMC011. Here, the structural studies reveal that bnAbs can take the advantage of the flexible and dynamic nature of the FP by recognizing it in multiple conformations and orientations and thereby facilitate interaction with the FP epitope by diverse antibodies, including different germlines, that can help aid in recognition and neutralization of HIV.
RESULTS
Crystal Structure of ACS202 Reveals FP Recognition A negative-stain single-particle EM reconstruction indicated that the ACS202 epitope was located in the gp120-gp41-interface . Competitive binding assays with other bnAbs to the interface region, including PGT151, 35O22, and 3BC315, strongly reduced ACS202 binding to SOSIP trimers. In addition, viruses with mutations in the FP were substantially resistant to ACS202 neutralization . To facilitate structural determination, we synthesized a peptide mimic of the AMC011 FP, which consisted of the first ten residues of the gp41 N terminus (residues 512-521, HXB2 numbering) and a C-terminal His 6 -tag (AVGIGAVFLGHHHHHH). A bio-layer interferometry (BLI) experiment showed that the ACS202 Fab binds the synthetic FP with a dissociation constant (K D ) of 1.8 mM (Figure S1E) , and binding was confirmed in an enzyme-linked immunosorbent assay (ELISA) ( Figure S1F ).
We determined a crystal structure of the ACS202 Fab in complex with the synthetic FP at 2.76-Å resolution (Figure 1 ; Table  S1 ). ACS202 has a 22-residue CDRH3 (Kabat numbering; Wu and Kabat, 1970;  Figure 1A ), which is longer than most human antibodies (Johnson and Wu, 1998) but not unusual for HIV-1 bnAbs, which often have CDRH3s that can extend from 20 to 38 residues (Sok and Burton, 2018; Yu and Guan, 2014) . The hexagonal crystals contained two ACS202 Fab molecules per asymmetric unit with one Fab bound to FP ( Figure S2A ), whereas the other Fab was unliganded because its paratope was blocked by a symmetry mate in the crystal ( Figure S2B ).
The ACS202 CDRs H2, H3, and L3 form a groove that accommodates the FP in an extended conformation ( Figures 1A and  1B) . The electron density for the FP is well defined ( Figures  S2C and S2D) , and all residues except 521 are visible. The FP exclusively consists of non-polar amino acids ( Figures 1D, S2C , and S2D). The FP extends along the length of a hydrophobic groove in the ACS202 combining site ( Figure 1B ) and is stabilized by eight backbone-mediated hydrogen bonds, thereby forming an antiparallel b sheet with CDRH3 ( Figures 1C and 1D ). The N-terminal FP residue, A512, inserts into a hydrophobic pocket formed by L94 and F96 of CDRL3 together with Y100 K of CDRH3, in an interaction that buries more than 90% of the A512 surface area ( Figure 1H ). The A512 interaction is further stabilized by three main-chain hydrogen bonds to Y91 of CDRL3 and Y100 K of CDRH3 (Figure 1E ). In CDRH3, 16 out of 22 residues are hydrophobic or aromatic (including glycines), especially on the C-terminal side of the H3 loop that is involved in binding the FP. The L100
L motif of CDRH3 forms intimate hydrophobic interactions with the FP ( Figure 1D ). The phenyl ring of F519 of the FP is further stabilized by a polar-p interaction (Dougherty, 2013) with the side-chain amine of CDRH3 N100 B ( Figure 1D ). The side chain of CDRH3 R100 F forms an additional hydrogen bond with the carbonyl oxygen of FP G516, which is further stabilized by interaction of its main-chain amide with the backbone of CDRH2 Q55 ( Figure 1F ). More than half of the total FP surface is buried in the interface with ACS202 and dominated by interactions with CDRH3 ( Figure 1G ). Each residue from A512 to F519 of the FP is buried by ACS202 ranging from 30% (V518) to 99% (G514) of the surface area, while L520 is completely exposed ( Figure 1H ), suggesting that ACS202 specifically recognizes only the first eight FP residues. The FP is an essential and highly conserved functional element of the HIV-1 Env trimer ( Figure S1 ); thus, if it is accessible, it is potentially a vulnerable site for antibodies to target. The most diverse residues within the HIV-1 FP are 515 and 518, where the hydrophobic amino acids found at these positions can vary ( Figure S1D ) (Crooks et al., 2004) . Among available HIV-1 sequences, the most common residue at position 515 is isoleucine (51.6%), while at position 518, valine is found in 43.6% of the sequences. Sequence diversity, particularly at these two positions, may therefore limit the neutralization breadth of Abs targeting the FP region. Thus, we individually introduced the less prevalent residues into the FP of the BG505-Env pseudovirus and assessed their impact on neutralization by ACS202, PGT151, and VRC34.01. In general, ACS202 and PGT151 were more tolerant of FP diversity at positions 515 and 518 than VRC34.01 (Figure S3A ). Binding assays involving the synthetic FPs confirmed this finding ( Figure S3B ). In particular, mutations at residue 518 substantially reduced binding and neutralization of VRC34.01, while ACS202 and PGT151 showed similar binding and neutralization. Inspection of the FP-complexes of ACS202, PGT151, and VRC34.01 indicated that the side chain of residue 518 is inserted within a hydrophobic pocket in VRC34.01 but, in contrast, is exposed in the ACS202 and PGT151 complexes ( Figures S3C,  S3D , and S3F). These findings imply that ACS202 and PGT151 have higher tolerance to FP diversity. We also found that V513A substitution (reflecting sequence differences found in a small percentage of HIV-1 strains) abolished FP binding of all three bnAbs ( Figure S3B ).
Conserved YYYY Motif of Antibodies Accommodates the N-Terminal Region of the FP
The YYYY motif of CDRH3 of ACS202 contributes to hydrophobic interactions with the FP ( Figure 1D ). Despite their different binding approach angles to the Env trimer and the different FP orientations stabilized by the two bnAbs ( Figure 4H ), ACS202 and PGT151 adopt similar strategies for interacting with the FP. In both cases, the CDRH3 loops form antiparallel b-sheet interactions with the FP (Figures S3C-S3E) , and the N-terminal A512 is buried in hydrophobic pockets formed by CDRL3 and CDRH3. For each bnAb, the CDRH3 YYYY motif makes hydrophobic stacking interactions with the N-terminal region ( 512 A-V-G-I 515 ) of the FP, although the motif is shifted by one residue in the respective CDRH3s ( Figure S3E ). These regions of ACS202 and PGT151 are encoded by a common IgHJ germline gene J6*02 (Ye et al., 2013) . Both bnAbs are highly conserved with their germline J gene. In both bnAbs, 18 out of 19 amino acids (95%) correspond to the germline-gene-encoded residues, including YYYY motifs ( Figure S3E ). (G) Surface area of the FP. The pie chart shows that more than half of the surface area of the FP is buried by ACS202 Fab, with CDRH3 contributing to most of that interaction. Colors for each CDR loop correspond to the panels above. ASA, accessible surface area. Buried and accessible areas were calculated with PISA (Proteins, Interfaces, Structures, and Assemblies) (Krissinel and Henrick, 2007) . (H) Surface area of each residue of the FP is shown in the bar chart, with buried surface area in gray and accessible area in white. Residues that form hydrogenbond interactions with ACS202 are highlighted with ''H'' on top of each bar. Buried and accessible surface areas are calculated with PISA (Krissinel and Henrick, 2007 
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J makes a side-by-side interaction with FP residue V513. Within the ACS202 family of Abs , the precise YYYY motif is present only in ACS202. In contrast, the corresponding motif in ACS201, 203, 204, and 205 is ''YHYY'' (Figure S1G); these nAbs bind less well to the FP than ACS202 ( Figure S1F) . A mutated version of ACS202 with Y100 J substituted by histidine (i.e., the YHYY motif) also bound less efficiently to AMC011 SOSIP.v4.2 (a recombinant autologous Env trimer of ACS202) and BG505 SOSIP.664 trimers, confirming the key contribution of the YYYY motif ( Figures S1H and S1I) . The Tyr/His polymorphism in the YYYY motif is not unique to the ACS202 family, as it is also present in PGT153-158, which are closely related to the YYYY-containing PGT151 . Despite the high flexibility and structural heterogeneity of the FP, both bnAbs ACS202 and PGT151 matured by developing the same consensus recognition features. In contrast, although VRC34.01 shares the same IgHJ germline gene J6*02 with ACS202 and PGT151, it has a relatively short CDRH3 of 13 residues, which does not contain the YYYY motif but NEAV at these positions .
Cryo-EM Structure Delineates the Complete Epitope of ACS202
The soluble, recombinant AMC011 SOSIP.v4.2 trimer is based on the consensus sequence from an early env gene (8 months post seroconversion) present in the ACS202 bnAb donor. ACS202 bnAb (isolated at 40 months post seroconversion) bound to this trimer with low nanomolar affinity and neutralized the consensus AMC011 virus . To further investigate the structural mechanism of binding and neutralization, we determined the cryo-EM structure of ACS202 Fab in complex with AMC011 SOSIP.v4.2 to 5.2 Å resolution ( Figures  2 and S2E) .
The structure reveals a stoichiometry of Fab:gp120-gp41 protomer of 1:1 (Figures 2A and 2B ). ACS202 binds perpendicular to the trimer 3-fold axis and parallel to the membrane with its heavy chain above the light chain (Figures 2A and 2B) . The bnAb recognizes a very similar conformation of the FP on the Env trimer and on the synthetic FP ( Figures 2C and 2D ). ACS202 also interacts with other regions of the gp120-gp41 interface, including a contiguous region of gp120 (residues 85-88) and glycans at N88 and N241 (Figure 2E) . The N88 glycan site is highly (>98%) conserved across different subtypes of HIV-1 Env ( Figure S1D ). Deletion of the N88 glycan completely abrogates ACS202 binding to the Env trimer and virus neutralization .
Residue 87 within interacting residues 85-88 is highly diverse with 56% of the analyzed sequences containing glutamate, 15% glycine, 13% lysine, and 16% other amino acids ( Figure S1D ). The cryo-EM structure of the AMC011 SOSIP.v4.2-ACS202 complex suggests that H53 CDRH2 and Q55 CDRH2 make contact with E87 ( Figure 2E ). Compared with wild-type ACS202, the H53A, Q55A, and Q55L mutants bind less well to the AMC011 SOSIP.v4.2 and BG505 SOSIP.664 trimers (Figures S4A and   S4B ). Furthermore, an E87A substitution in the AMC011 SOSIP.v4.2 trimer almost completely abolishes ACS202 binding and completely abrogates neutralization of JRCSF-Env pseudovirus . We assessed ACS202 binding to seven additional native-like SOSIP trimers based on sequences from subtypes A, B, and C ( Figure S4D ), all of which were predicted to contain the N88 glycan ( Figure S4E ). ACS202 was only minimally reactive with the two SOSIP trimers (B41 and ZM197M) in which residue 87 was a glycine rather than glutamate in the other five, ACS-reactive trimers. This finding is consistent with a previous neutralization study showing that all 32 ACS202-sensitive viruses contain a glutamate at position 87, while 26 of 42 non-neutralized viruses had a different residue (Figure S4F) . A logistic regression analysis also showed that sensitivity to ACS202 neutralization is highly correlated with the identity of residue 87, but is not correlated for VRC34.01 and PGT151 where residue 87 is not included in their epitopes (Figure S4G ). Finally, we showed that a G87E substitution in the B41 SOSIP.v4 trimer partially restores ACS202 binding ( Figure S4H ). Taken together, the various findings confirm the critical contribution of E87 to the ACS202 epitope. The natural sequence variation seen at this position would then appear to limit the neutralization breadth of ACS202 and could serve as an escape strategy. In fact, viruses that had escaped by mutation at position 87 were indeed found in the AMC011 individual .
Residue 85 is also diverse across HIV-1 strains ( Figure S1D ). The valine present in the AMC011 trimer at this position is involved in contacts with ACS202 ( Figure 2E ), and AMC011 virus neutralization was abrogated when V85 was changed to tryptophan . The VRC34.01 epitope also involves residue 85 ( Figure 3D ) and point substitutions at this position create VRC34.01 escape mutants (Dingens et al., 2018) . The FP has been shown to elicit cross-reactive neutralizing antibodies (nAbs) in animal studies when used as an immunogen , and these FP-elicited antibodies were also sensitive to single-site changes at residue 85 (Dingens et al., 2018) . Taken together, all known nAbs that recognize the FP, except for PGT151 (Dingens et al., 2019; Lee et al., 2016) , recognize their trimer epitopes through interaction with residues 85-88. Although the glycan site at N88 is highly conserved, the nearby residues at 85 and 87 are diverse; as these residues are critical for bnAb recognition, sequence variation here may limit the breadth of anti-FP nAbs.
ACS202 binding to Env proteins is highly cleavage dependent and does not bind to the uncleaved BG505 NFL Env construct ( Figure S4C ). Our structures show that the first FP residue is embedded within the antibody interface, and hydrogen bonds are made from the antibody to the free amino group of the FP. These N-terminal interactions are not possible on an uncleaved trimer like NFL (Sharma et al., 2015; Yang et al., 2018) , where the FP is still covalently attached to the gp120 subunit via a linker and oriented away from the gp120-gp41 interface. ACS202 and VRC34.01 Penetrate the HIV Glycan Shield HIV-1 Env is heavily glycosylated, with N-linked glycans comprising roughly half the mass of the glycoprotein. Collectively referred to as the glycan shield, the numerous glycans protect sites of vulnerability as an immune evasion strategy. Here, we considered whether this feature may also shield the FP from antibody recognition, but we found that ACS202 recognizes and penetrates the glycan shield at glycans N88 and N241 and is thus able to access and target the FP (Figure 2) . Previous studies have shown that VRC34.01 recognizes glycan N88 on the BG505 SOSIP.664 trimer . The BG505 virus lacks a glycan site at position 241 that is highly (>97%) conserved among global isolates (McCoy et al., 2016) . Knocking in a glycan at BG505 residue 241 does not alter VRC34.01 neutralization sensitivity, implying that this epitope is not shielded by a glycan at this position (Dingens et al., 2018) . We generated a 4.5 Å cryo-EM reconstruction of VRC34.01 with the same trimer (AMC011 SOSIP.v4.2) as in the ACS202 cryo-EM complex, which naturally contains a glycan at residue 241 ( Figures 3A, 3B , and S2F). The reconstruction shows that VRC34.01 does indeed penetrate between the N241 and N88 glycans to interact with the FP (Figure 3C ). The structure also demonstrates that VRC34.01 binds the FP in a very similar conformation in the AMC011 trimer to that identified in the crystal structure of VRC34.01 with the BG505 SOSIP.664 trimer (PDB: 5I8H) (Figures 3F, S2G , and S2H). However, the relative disposition of the FP on the Env surface differs and, therefore, the angle of approach of the antibodies. In the AMC011 trimer structure, the FP and the N88 glycan are reoriented by 11 and 16 , respectively, relative to the BG505.664 structure, and the binding angle of VRC34.01 shifts by 13
to avoid a clash with the additional glycan present at N241 ( Figure 3F ). Thus, anti-FP nAbs can alter their approach angle to penetrate through the glycan shield and, thereby, target this FP site of vulnerability.
DISCUSSION
Our X-ray and cryo-EM structural studies reveal how ACS202 binds to the FP of the HIV-1 envelope protein. Previously, two bnAbs, PGT151 and VRC34.01, have been shown to include the FP as a component of their overall epitopes Lee et al., 2016 ). An upward orientation of the FP is stabilized when PGT151 binds to a native Env trimer (Figures 4C and 4G, summarized in Table S2 ); the antibody also interacts with complex glycans at N611 and N637 on gp41 of the adjacent protomer (Lee et al., 2016) . The light chain is located above (i.e., more membrane-distal) the heavy chain and is mainly responsible for the glycan interactions. The heavy-chain-light-chain axis is more perpendicular to the membrane than VRC34.01. PGT151 binds to Env in an unusual asymmetric manner, with a maximum of two Fabs per trimer, presumably because of PGT151-induced allosteric effects that occlude the third binding site (Lee et al., 2016) . In contrast, the VRC34.01 binding angle is more parallel to the membrane plane and the antibody engages a downwardly oriented FP (Figures 4B and 4G) . As a result, and unlike PGT151, three VRC34.01 Fab molecules can bind symmetrically to each Env trimer. In addition to the FP, N88-glycans on the same protomer are bound by VRC34.01. Notwithstanding, PGT151 and VRC34.01 both stabilize the FP in an extended conformation. Recently, the FP was used as an immunogen to elicit mouse nAbs vFP16.02 and vFP20.01 ( Figures 4D  and 4E ) that have neutralization breadth of approximately 30% and stabilize a U-shaped conformation of the FP ( Figures 4G, S3G , and S3H).
ACS202 binds Env in a different mode to HIV-1 Env compared to these other bnAbs. When ACS202 binds, the FP is stabilized in an extended conformation with a slightly downward orientation that falls roughly between the PGT151 upward and the VRC34.01 downward orientations ( Figures 4A and 4G ). Compared to the VRC34.01-stabilized FP ( Figure S3F ), ACS202 recognizes the FP in an inverted orientation (rotation of 180 along the FP extended structure) ( Figures 3E and S3C) . Thus, the FP not only can adopt multiple positions and orientations but can also twist, thereby creating different conformations for recognition by nAbs. All known human anti-FP bnAbs to date also specifically recognize cleaved trimers, which is explained by the involvement of the free N-terminal residue, including the backbone, in their epitopes. PGT151 recognizes glycans, which occupy its major paratope interface, to a much greater extent than other anti-FP nAbs VRC34.01, vFP16.02, vFP20.01, and ACS202. Taken together, the flexibility of the FP and its ability to adopt different conformations and orientations (Gabrys et al., 2013; Kong et al., 2016; Lee et al., 2016; Sackett et al., 2014; Xu et al., 2018) , allows nAbs from different V H and V L germlines (Table S2) to bind with different approach angles and to incorporate a range of other peptide and glycan components (e.g., glycans at N88, N241, N611, and N637) in their epitopes. In addition, here, we show that the neutralization breadth of anti-FP nAbs is limited by multiple factors, including the natural diversity in FP sequences in gp41 and sensitivity to mutations on the gp120 component of the epitope. These factors should (legend continued on next page) be systematically considered when designing vaccines based wholly or in part on the FP. Since the first description of the HIV-1 Env trimer crystal and cryo-EM structures in 2013 Lyumkis et al., 2013) , many more have been obtained, involving a range of antibodies, subtypes, and at different levels of resolution (Chuang et al., 2019; Ward and Wilson, 2017) . The resulting body of information underpins our current understanding of the structure, mechanism, and biological role of Env and its recognition by bnAbs. Only some of the Env structures have experimentally observed density for the entire FP (Dingens et al., 2018; Kong et al., 2016; Kumar et al., 2019; Lee et al., 2016; Rantalainen et al., 2018; Sarkar et al., 2018; Stewart-Jones et al., 2016; Xu et al., 2018) . Despite its intrinsic flexibility, it has been essential to ascertain the range of possible conformations and locations of the FP to improve FP-epitope targeting. Here, our structure of the ACS202/Env complex describes a previously unobserved FP conformation; the FP is stabilized by an interaction with ACS202 that involves a binding angle distinct from the ones previously reported. The additional knowledge of how the FP adopts multiple conformations broadens our understanding of the range of possible antibody-recognition and antibody-elicitation strategies that can be used for HIV-1 vaccine design.
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